Its nationwide provider network, regulatory compliance, and reputation make it appealing for patients prioritizing safety and brand recognition
(NEJM, 2023) reported that Retatrutide (8mg dose) produced 24.2% mean body weight reduction at 48 weeks in adults with obesity
A recent poll among older adults found that 63 percent of people ages 50 to 80 who say they are overweight are interested in taking prescription weight loss medications
Headaches and fatigue can sometimes be linked to reduced calorie intake, dehydration, or electrolyte shifts
Cardel highlights the importance of focusing on water targets due to the potential muted signals caused by GLP-1 medications
Tirzepatide may lower blood pressure in some adults, especially those with obesity, excess weight, or metabolic health concerns